CN105152357B - A kind of pharmaceutical intermediate wastewater accelerant for biological treatment and preparation method and application - Google Patents
A kind of pharmaceutical intermediate wastewater accelerant for biological treatment and preparation method and application Download PDFInfo
- Publication number
- CN105152357B CN105152357B CN201510554987.6A CN201510554987A CN105152357B CN 105152357 B CN105152357 B CN 105152357B CN 201510554987 A CN201510554987 A CN 201510554987A CN 105152357 B CN105152357 B CN 105152357B
- Authority
- CN
- China
- Prior art keywords
- parts
- biological treatment
- accelerant
- pharmaceutical intermediate
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Activated Sludge Processes (AREA)
Abstract
The invention discloses a kind of pharmaceutical intermediate wastewater accelerant for biological treatment and preparation method and application, belong to field of waste water treatment.The accelerator is by glucose, ammonium phosphate, ethanol, phenol, calcium chloride, zinc chloride, magnesium sulfate, ferrous sulfate, vitamin B1, vitamin B12Compatibility is constituted, and is added it in pharmaceutical intermediate wastewater processing system, can promote the growth of microorganism, starts the Co metabolism effect of microorganism, resistance to poison of the microorganism to medicine intermediate is improved, so that the treatment pharmaceutical intermediate wastewater of efficient stable.The accelerator raw material sources extensively, prepare simple, easy to use, suitable pharmaceutical intermediate wastewater water quality characteristicses, have broad application prospects.
Description
Technical field
The present invention relates to the preparation and application of a kind of accelerant for biological treatment, more particularly to a kind of life of pharmaceutical intermediate wastewater
Thing treatment accelerator and preparation method and application, belongs to field of industrial waste water treatment, belongs to biological reinforcing technology category.
Background technology
Medicine intermediate production belongs to fine chemistry industry industry, mainly using the method for chemical reactive synthesis, by organic matter
Matter and inorganic substances are made synthetic drug and pharmaceutical intermediate.The main production of medicine intermediate is all chemical reaction, its
Because reactions steps are more in production process, using various chemical raw materials, production process raw material availability is low, and product yield is low, stream
Lose seriously, therefore contain miscellaneous toxic and harmful substance, such as amino benzenes compounds, nitro class chemical combination in this kind of waste water
Thing, arene compounds, halogenated hydrocarbon compound, organic solvent such as toluene, chloroform, petroleum ether, ethyl acetate, acetone etc., with
And the multiple pollutant such as spent acid alkali, inorganic salts.Therefore, pharmaceutical intermediate wastewater is the big industry of universally acknowledged difficulty of governance
One of waste water, it is difficult to which treatment up to standard is carried out to it using conventional bioremediation.
Biological reinforcing technology is by adding nutriment, five poisonous creatures: scorpion, viper, centipede, house lizard, toad surfactant, electron acceptor in contaminated environment
Or co-metabolic substance, the microorganism with degradation of contaminant ability itself existed in activation contaminated environment, make its active
To greatly improving, fast-growth is bred, so as to remove pollutant.Microorganism Co metabolism as biological reinforcing technology important hand
Section, is particularly suited for being difficult in biodegradable Industrial Wastewater Treatment, and co-metabolic substance is added in industrial wastewater, can promote
The growth of microorganism, starts the Co metabolism effect of microorganism, improves resistance to poison of the microorganism to organic pollution, and microorganism is in profit
While with these matrix, common oxidation or other reactions can occur to target contaminant, and excite rest cell to mesh
The metabolism of pollutant is marked, so that hardly degraded organic substance is able to degraded removal in industrial wastewater.
The content of the invention
It is big to pharmaceutical intermediate wastewater intractability in order to overcome the shortcomings of conventional biological treatment method, it is of the invention by biology
Microorganism Co metabolism is acted on and organically combined with conventional biological treatment method, i.e., add biological treatment in conventional biological treatment system
Accelerator, reaches the growth for promoting microorganism, the Co metabolism effect for starting microorganism, improves microorganism to the resistance to of organic pollution
The purpose of toxicity, rapid degradable organic pollutant.
In order to achieve the above object, the technical scheme is that, one：A kind of pharmaceutical intermediate wastewater biological treatment promotees
Enter agent；Secondly：The preparation method of the accelerant for biological treatment；Thirdly：The accelerant for biological treatment is at pharmaceutical intermediate wastewater
Application in reason.
One：A kind of pharmaceutical intermediate wastewater accelerant for biological treatment, is made up of following blend components and weight portion：
Glucose：30-60 parts；
Ammonium phosphate：10-20 parts；
Ethanol：10-20 parts；
Phenol：1-5 parts；
Calcium chloride：1-5 parts；
Zinc chloride：1-5 parts；
Magnesium sulfate：0.2-1 parts；
Ferrous sulfate：0.2-1 parts；
Vitamin B1：0.1-0.5 parts；
Vitamin B12：0.1-0.3 parts；
Water：200-300 parts.
Preferably, the accelerator is made up of following blend components and weight portion：
Glucose：40-50 parts；
Ammonium phosphate：12-15 parts；
Ethanol：15-18 parts；
Phenol：2-4 parts；
Calcium chloride：2-3 parts；
Zinc chloride：1-2 parts；
Magnesium sulfate：0.5-0.8 parts；
Ferrous sulfate：0.3-0.6 parts；
Vitamin B1：0.2-0.3 parts；
Vitamin B12：0.1-0.2 parts；
Water：250-300 parts.
It is furthermore preferred that the accelerator is made up of following blend components and weight portion：
Glucose：45 parts；
Ammonium phosphate：15 parts；
Ethanol：18 parts；
Phenol：3 parts；
Calcium chloride：2 parts；
Zinc chloride：1 part；
Magnesium sulfate：0.8 part；
Ferrous sulfate：0.4 part；
Vitamin B1：0.25 part；
Vitamin B12：0.15 part；
Water：280 parts.
Secondly：The preparation method of above-mentioned accelerant for biological treatment comprises the following steps：
(1) dissolve：The phenol and ethanol of weight portion are weighed, phenol is dissolved in ethanol, stirring accelerates its dissolving to obtain
Solution is 1.；Weigh glucose, ammonium phosphate, calcium chloride, zinc chloride, magnesium sulfate, ferrous sulfate, the vitamin B of weight portion1, dimension life
Plain B2, above-mentioned substance is dissolved in the water of weight portion, stirring accelerates its dissolving, obtains solution 2.；
(2) mix：1. solution is added to solution 2. in, stir 1-2 hour, make it well mixed, that is, in obtaining medicine
Mesosome biological wastewater treatment accelerator.
(3) store：The accelerant for biological treatment of preparation is kept in dark place, it is standby, for the treatment of pharmaceutical intermediate wastewater.
Thirdly：Application process of the above-mentioned accelerant for biological treatment in pharmaceutical intermediate wastewater treatment is as follows：
To be used after accelerant for biological treatment dilute with water, it is preferred that extension rate is 10 times；
Accelerant for biological treatment after dilution is added to the water inlet in biological treatment system；Preferably, at biology
Reason system is any of the conventional biological treatment techniques such as cyclic activated sludge system, SBR techniques, A/O techniques, AB techniques, contact oxidation technology
It is a kind of.
Accelerant for biological treatment after dilution adds ratio for 50-100mg/g (CODcr)。
Advantageous Effects of the invention are as follows：
1) raw material of the present invention is cheap and easy to get, scientific and reasonable according to pharmaceutical intermediate wastewater water quality compatibility, has microorganism life concurrently
Matrix long, energy matter, trace element and growth factor.Wherein glucose, ethanol and phenol are used as growth substrate, biological utilisation
Rate is high, enhances carbon source synergistic metabolism effect；Ammonium phosphate also provides nitrogen source and phosphorus source as energy matter, optimizes carbon N/P ratio,
Promote growth of microorganism；Calcium chloride, zinc chloride, magnesium sulfate and ferrous sulfate are strengthened to microorganism key enzyme as trace element
Induction and energy supply, be conducive to exciting rest cell to the degradation capability of target contaminant；Vitamin B1, vitamin B12Make
It is growth factor, promotes microbial growth, accelerates the foundation of Co metabolism system.The accelerator of above compatibility can effectively excite
Microorganism Co metabolism is acted on, metabolism of the enhancement microbiological to target contaminant.
6) preparation process is simple, is easy to storage, convenient and swift using process.Only need in conventional biological treatment system
Accelerator after the simple dosing dilution of water inlet, does not introduce other units and processing equipment, without any several inputs, should
With extensive, can be adapted to improve the reinforcing of existing sewage treatment facility efficiency using manually adding, without increasing energy consumption.
7) effect of biological micro-organism Co metabolism and conventional biological treatment method are organically combined, overcomes conventional biological treatment
The method deficiency big to pharmaceutical intermediate wastewater intractability, promotes the growth of microorganism, starts the Co metabolism effect of microorganism,
Microorganism is improved to the resistance to poison of organic pollution, the clearance of COD in waste water is not only greatly improved, and it is useless to degrade rapidly
Phenyl amines, aromatic hydrocarbons, halogenated hydrocarbon and various organic solvents in water.
8) treatment effect stabilization, processing cost is cheap, and the accelerant for biological treatment after 10 times of dilution adds ratio for 50-
100mg/g(CODcr).Pharmaceutical intermediate wastewater after treatment, COD, ammonia nitrogen removal frank more than 95%, aniline, halo
The persistence organic pollutant such as hydrocarbon clearance is respectively 80% and more than 85%.Waste water treatment efficiency is high, simple possible, is easy to work
Industryization is implemented.
Specific embodiment
Hereinafter the present invention will be further illustrated by specific embodiment, it will be understood by those skilled in the art that of the invention
Specific embodiment limits the present invention never in any form.Any equivalent each falls within guarantor of the invention on the basis of the present invention
Within the scope of shield.
Embodiment 1：
The preparation of pharmaceutical intermediate wastewater accelerant for biological treatment
Phenol 3kg is weighed, is dissolved in 18kg ethanol, stirring accelerates its dissolving to obtain solution 1.；Weigh glucose 45kg,
Ammonium phosphate 15kg, calcium chloride 2kg, zinc chloride 1kg, magnesium sulfate 0.8kg, ferrous sulfate 0.4kg, vitamin B10.25kg, dimension life
Plain B120.15kg, above-mentioned substance is dissolved in 280kg water, and stirring accelerates its dissolving, obtains solution 2.；1. solution is added
To solution 2. in, stir 1-2 hour, make it well mixed, that is, obtain pharmaceutical intermediate wastewater accelerant for biological treatment.
Embodiment 2：
The preparation of pharmaceutical intermediate wastewater accelerant for biological treatment
Phenol 2kg is weighed, is dissolved in 17kg ethanol, stirring accelerates its dissolving to obtain solution 1.；Weigh glucose 50kg,
Ammonium phosphate 12kg, calcium chloride 3kg, zinc chloride 2kg, magnesium sulfate 0.6kg, ferrous sulfate 0.5kg, vitamin B10.2kg, dimension life
Plain B120.2kg, by above-mentioned substance dissolving 300kg water, stirring accelerates its dissolving, obtains solution 2.；1. solution is added to molten
Liquid 2. in, stir 1-2 hour, make it well mixed, that is, obtain pharmaceutical intermediate wastewater accelerant for biological treatment.
Embodiment 3：
The preparation of pharmaceutical intermediate wastewater accelerant for biological treatment
Phenol 5kg is weighed, is dissolved in 18kg ethanol, stirring accelerates its dissolving to obtain solution 1.；Weigh glucose 40, phosphorus
Sour ammonium 18kg, calcium chloride 5kg, zinc chloride 2kg, magnesium sulfate 0.3kg, ferrous sulfate 0.5kg, vitamin B10.5kg, vitamin
B120.2kg, above-mentioned substance is dissolved in 260kg water, and stirring accelerates its dissolving, obtains solution 2.；1. solution is added to molten
Liquid 2. in, stir 1-2 hour, make it well mixed, that is, obtain pharmaceutical intermediate wastewater accelerant for biological treatment.
Embodiment 4：
The application of pharmaceutical intermediate wastewater accelerant for biological treatment
Certain pharmacy corporation mainly produces the medicine intermediates, its sewage disposal system such as cephalosporanic acid class, the southern class of training, miazines
Using cyclic activated sludge system as the aerobic stage of sewage disposal, after accelerant for biological treatment prepared by embodiment 1 dilutes 10 times, throw
The water inlet in CASS ponds is added to, ratio is added for 80mg/g (CODcr).Detection Inlet and outlet water water quality index, is shown in Table one.
Table one：Water quality index result list
As shown in Table 1：In with the system of cyclic activated sludge system treatment pharmaceutical intermediate wastewater, biological treatment of the present invention is being added
During accelerator, CODCr、NH3- N, aniline, the clearance of halogenated hydrocarbons are respectively 96.1%, 95.1%, 80.8%, 88.8%；And
When not adding accelerant for biological treatment of the present invention, CODCr、NH3- N, aniline, the clearance of halogenated hydrocarbons be respectively 87.5%,
74.6%th, 62.2%, 68.6%；After adding accelerant for biological treatment of the present invention in conventional cyclic activated sludge system, COD, ammonia nitrogen, benzene
Amine, the clearance of halogenated hydrocarbons are respectively increased 9.8%, 27.5%, 29.9% and 29.4%, and bioaugmentation is obvious.
Embodiment 5：
The Comparison study experiment of pharmaceutical intermediate wastewater accelerant for biological treatment
Experimental group：Accelerant for biological treatment prepared by embodiment 2.
Control group one：Accelerant for biological treatment prepared by embodiment 2 is made into following formula to change：Weigh glucose 50kg,
Ammonium phosphate 22kg, ethanol 17kg, zinc chloride 2kg, magnesium sulfate 0.6kg, ferrous sulfate 0.5kg, vitamin B120.2kg, will be above-mentioned
In material dissolving 300kg water, stirring accelerates its dissolving, stirs 1-2 hours, is well mixed it, obtains at the biology of control group one
Reason accelerator.
Control group two：Dyeing and Printing Wastewater Biological Treatment accelerator prepared by embodiment 2 is made following formula and is changed：Weigh phenol
6kg, is dissolved in 25kg ethanol, and stirring accelerates its dissolving to obtain solution 1.；Weigh glucose 25kg, ammonium phosphate 12kg, chlorination
Calcium 7kg, zinc chloride 0.8kg, magnesium sulfate 1.5kg, ferrous sulfate 0.1kg, vitamin B11kg, vitamin B120.06kg, will be upper
State in material dissolving 300kg water, stirring accelerates its dissolving, obtains solution 2.；1. solution is added to solution 2. in, stir 1-2
Hour, be well mixed it, that is, obtain the accelerant for biological treatment of control group two.
Blank group：Accelerant for biological treatment is not added
Contrast treatment is carried out to certain pharmaceutical intermediate wastewater in laboratory day treatment wastewater flow rate is for the sbr reactor device of 200L
Experiment.After the experimental group of above-mentioned preparation, control group one, the accelerant for biological treatment of control group two are diluted into 10 times, add respectively
To the water inlet of contact-oxidation pool, the ratio of adding is 100mg/g (CODcr).Detection Inlet and outlet water water quality index, is shown in Table two.
Table two：Water quality index comparing result list
As shown in Table 2：In with the system of contact oxidation technology treatment pharmaceutical intermediate wastewater, biology of the invention is being added
During treatment accelerator, CODCr、NH3- N, aniline, the clearance of halogenated hydrocarbons are respectively 95.9%, 95.2%, 81.3%, 88.5%；
(remove phenol, calcium chloride, the vitamin B in formula when the accelerant for biological treatment of control group one is added1), CODCr、NH3-
N, aniline, the clearance of halogenated hydrocarbons are respectively 87.9%, 77.1%, 65.3%, 70.5%；At the biology for adding control group two
(weight portion of each component is not in ratio range of the present invention in formula), COD during reason acceleratorCr、NH3- N, aniline, halogenated hydrocarbons
Clearance is respectively 86.9%, 70.2%, 59.5%, 62.1%；When accelerant for biological treatment of the present invention is not added, CODCr、
NH3- N, aniline, the clearance of halogenated hydrocarbons are respectively 87.2%, 72.6%, 69.9%, 75.8%.It can be seen that, it is each in control group one
The clearance of polluter is significantly lower than experimental group, and suitable with blank group, and microorganism is not excited in this explanation control group one
Co metabolism effect.The clearance of each polluter is significantly lower than experimental group, even below blank group, this explanation in control group two
Because proportioning exceeds ratio range of the present invention in control group two, do not excite not only the Co metabolism of microorganism to act on, instead result in
The disorder of processing system.Therefore, the compatibility composition and weight of accelerant for biological treatment of the present invention can not arbitrarily change,
Change compatibility composition and beyond ratio range, can not effectively process pharmaceutical intermediate wastewater.
Claims (9)
1. a kind of pharmaceutical intermediate wastewater accelerant for biological treatment, it is characterised in that be made up of following blend components, each component and
Its weight portion is constituted：
Glucose：40-50 parts；
Ammonium phosphate：12-15 parts；
Ethanol：15-18 parts；
Phenol：2-4 parts；
Calcium chloride：2-3 parts；
Zinc chloride：1-2 parts；
Magnesium sulfate：0.5-0.8 parts；
Ferrous sulfate：0.3-0.6 parts；
Vitamin B1：0.2-0.3 parts；
Vitamin B12：0.1-0.2 parts；
Water：250-300 parts.
2. pharmaceutical intermediate wastewater accelerant for biological treatment as claimed in claim 1, it is characterised in that by following blend components
Composition, each component and its weight portion composition are：
Glucose：45 parts；
Ammonium phosphate：15 parts；
Ethanol：18 parts；
Phenol：3 parts；
Calcium chloride：2 parts；
Zinc chloride：1 part；
Magnesium sulfate：0.8 part；
Ferrous sulfate：0.4 part；
Vitamin B1：0.25 part；
Vitamin B12：0.15 part；
Water：280 parts.
3. the preparation method of the pharmaceutical intermediate wastewater accelerant for biological treatment as described in claim 1-2 is any, its feature exists
In comprising the following steps：
(1) dissolve：The phenol and ethanol of weight portion are weighed, phenol is dissolved in ethanol, stirring accelerates its dissolving to obtain solution
①；Weigh glucose, ammonium phosphate, calcium chloride, zinc chloride, magnesium sulfate, ferrous sulfate, the vitamin B of weight portion1, vitamin B12,
Above-mentioned substance is dissolved in the water of weight portion, stirring accelerates its dissolving, obtains solution 2.；
(2) mix：1. solution is added to solution 2. in, stir 1-2 hour, make it well mixed, that is, obtain medicine intermediate
Biological wastewater treatment accelerator；
(3) store：The accelerant for biological treatment of preparation is kept in dark place, it is standby, for the treatment of pharmaceutical intermediate wastewater.
4. the pharmaceutical intermediate wastewater accelerant for biological treatment as described in claim 1-2 is any is in pharmaceutical intermediate wastewater treatment
In application.
5. application as claimed in claim 4, it is characterised in that will be used after accelerant for biological treatment dilute with water.
6. application as claimed in claim 5, it is characterised in that extension rate is 10 times.
7. application as claimed in claim 6, it is characterised in that the accelerant for biological treatment after dilution is added to biological treatment
Water inlet in system.
8. application as claimed in claim 7, it is characterised in that add ratio for 50-100mg/g (CODcr)。
9. application as claimed in claim 8, it is characterised in that the biological treatment system is cyclic activated sludge system, SBR techniques, A/O
Any one in technique, AB techniques, contact oxidation technology.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510554987.6A CN105152357B (en) | 2015-09-05 | 2015-09-05 | A kind of pharmaceutical intermediate wastewater accelerant for biological treatment and preparation method and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510554987.6A CN105152357B (en) | 2015-09-05 | 2015-09-05 | A kind of pharmaceutical intermediate wastewater accelerant for biological treatment and preparation method and application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105152357A CN105152357A (en) | 2015-12-16 |
| CN105152357B true CN105152357B (en) | 2017-06-06 |
Family
ID=54793485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510554987.6A Active CN105152357B (en) | 2015-09-05 | 2015-09-05 | A kind of pharmaceutical intermediate wastewater accelerant for biological treatment and preparation method and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105152357B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109626550A (en) * | 2018-12-29 | 2019-04-16 | 凯瑞斯德生化(苏州)有限公司 | The application of 5,6- dihydro -4- hydroxyl -6- methylthiophene [2,3-b] sulphur pyrans -7,7- dioxide |
| CN113461150B (en) * | 2021-07-28 | 2022-03-11 | 湖北亮绿环保技术有限公司 | Treatment process of medical intermediate chemical wastewater |
| CN113998789A (en) * | 2021-10-29 | 2022-02-01 | 中原环保股份有限公司 | COD for domestic sewage treatmentCrBiological removal promoter and preparation method thereof |
| CN115231716B (en) * | 2022-08-02 | 2024-05-10 | 河南君和环保科技有限公司 | Biological promoter for treating wastewater produced by ion exchange resin, and preparation method and application thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012079140A1 (en) * | 2010-12-14 | 2012-06-21 | Gustavo Casal De Rey | Biostimulation and bioenhancing processes for treating domestic and industrial effluents |
| CN103848504A (en) * | 2012-11-28 | 2014-06-11 | 沈阳铝镁设计研究院有限公司 | Biological enhancer, its preparation method and application method thereof |
| CN104711213A (en) * | 2015-03-13 | 2015-06-17 | 中国海洋石油总公司 | Accelerant facilitating growth of salt-resistive nitrifying bacteria in high-salt wastewater |
-
2015
- 2015-09-05 CN CN201510554987.6A patent/CN105152357B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012079140A1 (en) * | 2010-12-14 | 2012-06-21 | Gustavo Casal De Rey | Biostimulation and bioenhancing processes for treating domestic and industrial effluents |
| CN103848504A (en) * | 2012-11-28 | 2014-06-11 | 沈阳铝镁设计研究院有限公司 | Biological enhancer, its preparation method and application method thereof |
| CN104711213A (en) * | 2015-03-13 | 2015-06-17 | 中国海洋石油总公司 | Accelerant facilitating growth of salt-resistive nitrifying bacteria in high-salt wastewater |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105152357A (en) | 2015-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhang et al. | Denitrification of groundwater using a sulfur-oxidizing autotrophic denitrifying anaerobic fluidized-bed MBR: performance and bacterial community structure | |
| Yang et al. | Dominant denitrifying bacteria are important hosts of antibiotic resistance genes in pig farm anoxic-oxic wastewater treatment processes | |
| Ding et al. | Biological treatment of actual petrochemical wastewater using anaerobic/anoxic/oxic process and the microbial diversity analysis | |
| CN105152357B (en) | A kind of pharmaceutical intermediate wastewater accelerant for biological treatment and preparation method and application | |
| Xiao et al. | Enhanced nitrogen removal from high-strength ammonium wastewater by improving heterotrophic nitrification-aerobic denitrification process: insight into the influence of dissolved oxygen in the outer layer of the biofilm | |
| Wang et al. | Enhanced removal of cephalexin and sulfadiazine in nitrifying membrane-aerated biofilm reactors | |
| Wang et al. | Toxic effects of oxytetracycline and copper, separately or combined, on soil microbial biomasses | |
| Wu et al. | Rapid start-up and stable maintenance of partial nitrification–anaerobic ammonium oxidation treatment of landfill leachate at low temperatures | |
| Daraei et al. | Biotoxicity evaluation of zinc oxide nanoparticles on bacterial performance of activated sludge at COD, nitrogen, and phosphorus reduction | |
| Zhao et al. | Application of humic acid changes the microbial communities and inhibits the expression of tetracycline resistance genes in 4-chlorophenol wastewater treatment | |
| Yang et al. | The SBR start-up performing simultaneous removal of organics, nitrogen and phosphorus from aniline wastewater: Pollutant removal efficiency and microbial community succession | |
| Zhang et al. | The efficiency of integrated wastewater treatment plant for pollutant removal from industrial-scale lincomycin production | |
| Wu et al. | Removal of pharmaceuticals by ammonia oxidizers during nitrification | |
| Zhang et al. | Fate of antibiotic resistance genes and bacteria in a coupled water-processing system with wastewater treatment plants and constructed wetlands in coastal eco-industrial parks | |
| Li et al. | Effects of combined 4-chlorophenol and Cu2+ on functional genes for nitrogen and phosphorus removal and heavy metal resistance genes in sequencing batch bioreactors | |
| Wei et al. | Aerobic biodegradation of 2, 6-dichlorophenol in a nitrifying granular sludge reactor: system performance and microbial community evolution | |
| Hao et al. | Achieving tetracycline removal enhancement with granules in marine matrices: Performance, adaptation, and mechanism studies | |
| Hu et al. | Adaptation of anammox process for nitrogen removal from acidic nitritation effluent in a low pH moving bed biofilm reactor | |
| Hu et al. | Removal of ammonia nitrogen from residual ammonium leaching solution by heterotrophic nitrification-aerobic denitrification process | |
| Su et al. | Pilot-scale demonstration of self-enrichment of anammox bacteria in a two-stage nitrification-denitrification suspended sludge system treating municipal wastewater under extremely low nitrogen loading rate | |
| Zhang et al. | Effects of zero-valent iron (ZVI) on nitrogen conversion, transformation of sulfamethoxazole (SMX) and abundance of antibiotic resistance genes (ARGs) in aerobic granular sludge process | |
| Rivera et al. | Low maintenance anammox enrichment and nitrogen removal with an anaerobic baffled reactor | |
| Zhu et al. | Deciphering the response of heterotrophic, autotrophic and mixotrophic denitrification to enrofloxacin stress: Performance, denitrifying community and antibiotic resistance genes | |
| Chen et al. | O/H/H/O process for total nitrogen removal: an upgrade of the A/A/O process for coking wastewater treatment | |
| CN100460498C (en) | Sequencing batch active sludge process for eliminating ammonia nitrogen from sewage |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB03 | Change of inventor or designer information | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhu Kengteng Inventor after: Yang Jinhua Inventor before: Wang Lei |
|
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20170511 Address after: 362100 Huian County, Fujian province Tu Tu Tu village Applicant after: Quanzhou East Trading Co., Ltd. Address before: The 277719 Shandong province Linyi Lanling County Township Xue Village No. 431 Applicant before: Wang Lei |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20190327 Address after: 226156 999 Harbour Road, Binhai New Area, Haimen, Nantong, Jiangsu Patentee after: HAIMEN HUANGHAI PIONEER PARK SERVICES CO., LTD. Address before: 362100 Tuzhai Village, Tuzhai Town, Huian County, Quanzhou City, Fujian Province Patentee before: Quanzhou East Trading Co., Ltd. |